These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Prevention of postoperative recurrence after hepatic resection for metastatic colorectal cancer by adjuvant locoregional chemotherapy]. Endo Y; Tani T; Kawaguchi A; Eguchi Y; Sano H; Kurumi Y; Hanasawa K; Ishibashi H; Terata N; Shibata J Gan To Kagaku Ryoho; 1993 Aug; 20(11):1535-7. PubMed ID: 8396906 [TBL] [Abstract][Full Text] [Related]
25. Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial. Hasegawa K; Takayama T; Ijichi M; Matsuyama Y; Imamura H; Sano K; Sugawara Y; Kokudo N; Makuuchi M Hepatology; 2006 Oct; 44(4):891-5. PubMed ID: 17006925 [TBL] [Abstract][Full Text] [Related]
26. Postoperative prediction of and strategy for metastatic recurrent hepatocellular carcinoma according to histologic activity of hepatitis. Ueno S; Tanabe G; Yoshida A; Yoshidome S; Takao S; Aikou T Cancer; 1999 Jul; 86(2):248-54. PubMed ID: 10421260 [TBL] [Abstract][Full Text] [Related]
27. Lipiodolization prolongs survival rates in postoperative patients with a recurrent hepatocellular carcinoma. Furuta T; Kanematsu T; Matsumata T; Shirabe K; Yamagata M; Utsunomiya T; Sugimachi K Hepatogastroenterology; 1990 Oct; 37(5):494-7. PubMed ID: 2174829 [TBL] [Abstract][Full Text] [Related]
28. Chemoembolization and percutaneous ethanol injection for intrahepatic recurrence of hepatocellular carcinoma after hepatic resection. Sato M; Watanabe Y; Iseki N; Ueda S; Kawach K; Kimura S; Itoh Y; Ohkubo K; Onji M Hepatogastroenterology; 1996; 43(12):1421-6. PubMed ID: 8975942 [TBL] [Abstract][Full Text] [Related]
29. Surgical outcome of patients with hepatocellular carcinoma originating in the caudate lobe. Tanaka S; Shimada M; Shirabe K; Maehara S; Tsujita E; Taketomi A; Maehara Y Am J Surg; 2005 Sep; 190(3):451-5. PubMed ID: 16105535 [TBL] [Abstract][Full Text] [Related]
30. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma. Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222 [TBL] [Abstract][Full Text] [Related]
31. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection. Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934 [TBL] [Abstract][Full Text] [Related]
32. Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm. Maluccio M; Covey AM; Gandhi R; Gonen M; Getrajdman GI; Brody LA; Fong Y; Jarnagin W; D'Angelica M; Blumgart L; DeMatteo R; Brown KT J Vasc Interv Radiol; 2005 Jul; 16(7):955-61. PubMed ID: 16002503 [TBL] [Abstract][Full Text] [Related]
34. [Regional therapy to prevent recurrence after surgery in hepatocellular carcinoma]. Sasaki Y; Imaoka S; Masutani S; Ohashi I; Iwamoto S; Nakamori S; Ohigashi H; Kameyama M; Hiratsuka M; Ishikawa O Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1767-70. PubMed ID: 1326927 [TBL] [Abstract][Full Text] [Related]
35. Longterm prognosis after hepatic resection for small hepatocellular carcinoma. Shimozawa N; Hanazaki K J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736 [TBL] [Abstract][Full Text] [Related]
36. [Studies on the effectiveness of adjuvant hepatic arterial chemotherapy after hepatectomy for primary or metastatic liver cancer]. Isshiki K; Nonami T; Kishimoto W; Katoh H; Akaza K; Harada A; Nakao A; Takagi H Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1634-7. PubMed ID: 2167638 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of major hepatectomy for large hepatocellular carcinoma. Miyoshi A; Takahashi T; Otsuka T; Kohya N; Miyazaki K Hepatogastroenterology; 2009; 56(91-92):768-72. PubMed ID: 19621699 [TBL] [Abstract][Full Text] [Related]
38. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H; J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896 [TBL] [Abstract][Full Text] [Related]
39. [Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis]. Lim TY; Cheong JY; Cho SW; Sim SJ; Kim JS; Choi SJ; Choi JW; Kwon HC; Lee KM; Kim JK; Won JH; Yoo BM; Lee KJ; Hahm KB; Kim JH Korean J Hepatol; 2006 Mar; 12(1):65-73. PubMed ID: 16565607 [TBL] [Abstract][Full Text] [Related]
40. [Clinical study of adjuvant individualized chemotherapy for hepatocellular carcinoma after liver transplantation]. Chen GH; Lu MQ; Cai CJ; Yang Y; He XS; Zhu XF Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1040-3. PubMed ID: 15498315 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]